Cargando…
High-Dose Mannose-Binding Lectin Therapy for Ebola Virus Infection
Mannose-binding lectin (MBL) targets diverse microorganisms for phagocytosis and complement-mediated lysis by binding specific surface glycans. Although recombinant human MBL (rhMBL) trials have focused on reconstitution therapy, safety studies have identified no barriers to its use at higher levels...
Autores principales: | Michelow, Ian C., Lear, Calli, Scully, Corinne, Prugar, Laura I., Longley, Clifford B., Yantosca, L. Michael, Ji, Xin, Karpel, Marshall, Brudner, Matthew, Takahashi, Kazue, Spear, Gregory T., Ezekowitz, R. Alan B., Schmidt, Emmett V., Olinger, Gene G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071052/ https://www.ncbi.nlm.nih.gov/pubmed/21288816 http://dx.doi.org/10.1093/infdis/jiq025 |
Ejemplares similares
-
Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors
por: Brudner, Matthew, et al.
Publicado: (2013) -
The mannose-binding lectin: a prototypic pattern recognition molecule
por: Takahashi, Kazue, et al.
Publicado: (2006) -
The Mannose-Binding Lectin: An Infection Susceptibility Gene
por: Ezekowitz, R. Alan, et al.
Publicado: (2005) -
Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome
por: Ip, W.K. Eddie, et al.
Publicado: (2008) -
Mannose-binding Lectin-deficient Mice Are Susceptible to Infection with Staphylococcus aureus
por: Shi, Lei, et al.
Publicado: (2004)